News & Updates

In the treatment of patients with Parkinson disease (PD), nicotinamide riboside does not appear to confer beneficial effects and is even associated with worse clinical outcomes compared with placebo, according to a phase III trial.

Treatment with tozorakimab as an add-on to inhaled maintenance therapy helps lessen the frequency of moderate or severe chronic obstructive pulmonary disease (COPD) exacerbations, and this benefit is observed in both former and current smokers.

Activin A blockade with garetosmab suppresses heterotopic ossification in adults with the ultra-rare genetic disorder fibrodysplasia ossificans progressiva (FOP), according to findings from the phase III OPTIMA trial that served as the basis for its Food and Drug Administration (FDA) approval.

In children receiving myelosuppressive chemotherapy for cancer, prophylactic treatment with romiplostim helps reduce bleeding and the need for blood transfusion despite having no effect on the speed of platelet recovery, as shown in a study.

A gamified tool dubbed ChemINJ offers a playful approach to improving knowledge on the preparation of anticancer medications, according to a study, which suggests its integration into student curricula.

The use of axitinib in combination with pembrolizumab demonstrates efficacy in the treatment of metastatic renal cell carcinoma (mRCC), according to a real-world study.